Loading...

Tzu-Yin Lin

Title(s)Assistant Researcher, Hematology and Oncology
SchoolUniversity of California, Davis
AddressCancer Ctr So, #3016
CA 95817
Phone916-734-3772
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Excipient-free porphyrin/SN-38 based nanotheranostics for drug delivery and cell imaging. Nano Research. 2020 Feb 1; 13(2):503-510. Ye Yuan, Ruonan Bo, Di Jing, Zhao Ma, Zhongling Wang, Tzu-yin Lin, Lijie Dong, Xiangdong Xue, Yuanpei Li. .
      View in: Publisher Site   Mentions:
    2. Peptide-based materials for cancer immunotherapy. Theranostics. 2019; 9(25):7807-7825. Zhang L, Huang Y, Lindstrom AR, Lin TY, Lam KS, Li Y. PMID: 31695802.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    3. Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia. Nanomedicine. 2019 08; 20:102004. Lin TY, Zhu Y, Li Y, Zhang H, Ma AH, Long Q, Keck J, Lam KS, Pan CX, Jonas BA. PMID: 31055076.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    4. A facile approach to fabricate self-assembled magnetic nanotheranostics for drug delivery and imaging. Nanoscale. 2018 Nov 29; 10(46):21634-21639. Yuan Y, He Y, Bo R, Ma Z, Wang Z, Dong L, Lin TY, Xue X, Li Y. PMID: 30457141.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    5. A polymer-free, biomimicry drug self-delivery system fabricated via a synergistic combination of bottom-up and top-down approaches. J Mater Chem B. 2018 12 21; 6(47):7842-7853. Xu X, Yang G, Xue X, Lu H, Wu H, Huang Y, Jing D, Xiao W, Tian J, Yao W, Pan CX, Lin TY, Li Y. PMID: 31380107.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    6. Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nat Commun. 2018 09 07; 9(1):3653. Xue X, Huang Y, Bo R, Jia B, Wu H, Yuan Y, Wang Z, Ma Z, Jing D, Xu X, Yu W, Lin TY, Li Y. PMID: 30194413.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    7. A highly integrated precision nanomedicine strategy to target esophageal squamous cell cancer molecularly and physically. Nanomedicine. 2018 10; 14(7):2103-2114. Wang XS, Ding XZ, Li XC, He Y, Kong DJ, Zhang L, Hu XC, Yang JQ, Zhao MQ, Gao SG, Lin TY, Li Y. PMID: 30047470.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    8. Novel redox-responsive polymeric magnetosomes with tunable magnetic resonance property for in vivo drug release visualization and dual-modal cancer therapy. Adv Funct Mater. 2018 Aug 15; 28(33). Wang Z, Xue X, He Y, Lu Z, Jia B, Wu H, Yuan Y, Huang Y, Wang H, Lu H, Lam KS, Lin TY, Li Y. PMID: 31303869.
      View in: PubMed   Mentions:
    9. Nanoformulated paclitaxel and AZD9291 synergistically eradicate non-small-cell lung cancers in vivo. Nanomedicine (Lond). 2018 05; 13(10):1107-1120. Wang XS, Zhang L, Li X, Kong DJ, Hu XC, Ding XZ, Yang JQ, Zhao MQ, He Y, Lam KS, Gao SG, Lin TY, Li Y. PMID: 29874151.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    10. Self-indicating, fully active pharmaceutical ingredients nanoparticles (FAPIN) for multimodal imaging guided trimodality cancer therapy. Biomaterials. 2018 04; 161:203-215. Xue X, Huang Y, Wang X, Wang Z, Carney RP, Li X, Yuan Y, He Y, Lin TY, Li Y. PMID: 29421556.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    11. Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model. Nanomedicine. 2018 04; 14(3):789-799. Long Q, Lin TY, Huang Y, Li X, Ma AH, Zhang H, Carney R, Airhart S, Lam KS, deVere White RW, Pan CX, Li Y. PMID: 29317342.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    12. COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther. 2018 02; 17(2):474-483. Wang F, Zhang H, Ma AH, Yu W, Zimmermann M, Yang J, Hwang SH, Zhu D, Lin TY, Malfatti M, Turteltaub KW, Henderson PT, Airhart S, Hammock BD, Yuan J, de Vere White RW, Pan CX. PMID: 29284644.
      View in: PubMed   Mentions:
    13. "One-Pot" Fabrication of Highly Versatile and Biocompatible Poly(vinyl alcohol)-porphyrin-based Nanotheranostics. Theranostics. 2017; 7(16):3901-3914. Luo Y, Wu H, Feng C, Xiao K, Yang X, Liu Q, Lin TY, Zhang H, Walton JH, Ajena Y, Hu Y, Lam KS, Li Y. PMID: 29109786.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    14. Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer. J Control Release. 2017 Oct 28; 264:169-179. Xiao W, Suby N, Xiao K, Lin TY, Al Awwad N, Lam KS, Li Y. PMID: 28847739.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    15. The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer. Clin Cancer Res. 2017 Nov 01; 23(21):6580-6591. Zeng SX, Zhu Y, Ma AH, Yu W, Zhang H, Lin TY, Shi W, Tepper CG, Henderson PT, Airhart S, Guo JM, Xu CL, deVere White RW, Pan CX. PMID: 28808038.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    16. Sub-100nm, long tumor retention SN-38-loaded photonic micelles for tri-modal cancer therapy. J Control Release. 2017 09 10; 261:297-306. Yang X, Xue X, Luo Y, Lin TY, Zhang H, Lac D, Xiao K, He Y, Jia B, Lam KS, Li Y. PMID: 28700898.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    17. A facile strategy for fine-tuning the stability and drug release of stimuli-responsive cross-linked micellar nanoparticles towards precision drug delivery. Nanoscale. 2017 Jun 14; 9(23):7765-7770. Xiao K, Lin TY, Lam KS, Li Y. PMID: 28585953.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    18. A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer. Acta Pharmacol Sin. 2017 Jun; 38(6):931-942. Wang XS, Kong DJ, Lin TY, Li XC, Izumiya Y, Ding XZ, Zhang L, Hu XC, Yang JQ, Gao SG, Lam KS, Li YP. PMID: 28552907.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    19. A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancer. Int J Cancer. 2017 08 01; 141(3):604-613. Wang SS, Zimmermann M, Zhang H, Lin TY, Malfatti M, Haack K, Turteltaub KW, Cimino GD, de Vere White R, Pan CX, Henderson PT. PMID: 28437852.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice. Mol Cancer Ther. 2017 02; 16(2):376-387. Zimmermann M, Wang SS, Zhang H, Lin TY, Malfatti M, Haack K, Ognibene T, Yang H, Airhart S, Turteltaub KW, Cimino GD, Tepper CG, Drakaki A, Chamie K, de Vere White R, Pan CX, Henderson PT. PMID: 27903751.
      View in: PubMed   Mentions:
    21. Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer. Nanotechnology. 2016 Oct 21; 27(42):425103. Pan A, Zhang H, Li Y, Lin TY, Wang F, Lee J, Cheng M, Dall'Era M, Li T, deVere White R, Pan CX, Lam KS. PMID: 27640312.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    22. Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer. Biomaterials. 2016 10; 104:339-51. Lin TY, Li Y, Liu Q, Chen JL, Zhang H, Lac D, Zhang H, Ferrara KW, Wachsmann-Hogiu S, Li T, Airhart S, deVere White R, Lam KS, Pan CX. PMID: 27479049.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    23. HSP90 Inhibitor Encapsulated Photo-Theranostic Nanoparticles for Synergistic Combination Cancer Therapy. Theranostics. 2016; 6(9):1324-35. Lin TY, Guo W, Long Q, Ma A, Liu Q, Zhang H, Huang Y, Chandrasekaran S, Pan C, Lam KS, Li Y. PMID: 27375782.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    24. Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer. PLoS One. 2016; 11(1):e0146256. Wang S, Zhang H, Scharadin TM, Zimmermann M, Hu B, Pan AW, Vinall R, Lin TY, Cimino G, Chain P, Vuyisich M, Gleasner C, Mcmurry K, Malfatti M, Turteltaub K, de Vere White R, Pan CX, Henderson PT. PMID: 26799320.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    25. Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity. Chem Res Toxicol. 2015 Dec 21; 28(12):2250-2. Jiang S, Pan AW, Lin TY, Zhang H, Malfatti M, Turteltaub K, Henderson PT, Pan CX. PMID: 26544157.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    26. Smart and Fast Blood Counting of Trace Volumes of Body Fluids from Various Mammalian Species Using a Compact, Custom-Built Microscope Cytometer. Anal Chem. 2015 Dec 01; 87(23):11854-62. Gao T, Smith ZJ, Lin TY, Carrade Holt D, Lane SM, Matthews DL, Dwyre DM, Hood J, Wachsmann-Hogiu S. PMID: 26496235.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    27. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy. PLoS One. 2015; 10(8):e0134346. Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW. PMID: 26270481.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    28. Nanomedicine in veterinary oncology. Vet J. 2015 Aug; 205(2):189-97. Lin TY, Rodriguez CO, Li Y. PMID: 25862394.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    29. Nanotechnology in bladder cancer: current state of development and clinical practice. Nanomedicine (Lond). 2015; 10(7):1189-201. Tomlinson B, Lin TY, Dall'Era M, Pan CX. PMID: 25929573.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    30. Urethral reconstruction with tissue-engineered human amniotic scaffold in rabbit urethral injury models. Med Sci Monit. 2014 Nov 26; 20:2430-8. Wang F, Liu T, Yang L, Zhang G, Liu H, Yi X, Yang X, Lin TY, Qin W, Yuan J. PMID: 25424000.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    31. A smart and versatile theranostic nanomedicine platform based on nanoporphyrin. Nat Commun. 2014 Aug 26; 5:4712. Li Y, Lin TY, Luo Y, Liu Q, Xiao W, Guo W, Lac D, Zhang H, Feng C, Wachsmann-Hogiu S, Walton JH, Cherry SR, Rowland DJ, Kukis D, Pan C, Lam KS. PMID: 25158161.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansAnimalsCells
    32. Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin. Nanomedicine (Lond). 2014; 9(12):1807-20. Zhang H, Li Y, Lin TY, Xiao K, Haddad AS, Henderson PT, Jonas BA, Chen M, Xiao W, Liu R, Lam KS, Pan CX. PMID: 24628688.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    33. Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis. BMC Cancer. 2014 Feb 11; 14:84. Fenger JM, Bear MD, Volinia S, Lin TY, Harrington BK, London CA, Kisseberth WC. PMID: 24517413.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    34. Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer. Nanomedicine (Lond). 2013 Aug; 8(8):1239-51. Lin TY, Li YP, Zhang H, Luo J, Goodwin N, Gao T, White Rde V, Lam KS, Pan CX. PMID: 23199207.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    35. Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. Int J Nanomedicine. 2012; 7:2793-804. Lin TY, Zhang H, Luo J, Li Y, Gao T, Lara PN, de Vere White R, Lam KS, Pan CX. PMID: 22745542.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    36. Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand. Mol Cancer. 2011 Jan 27; 10(1):9. Lin TY, Zhang H, Wang S, Xie L, Li B, Rodriguez CO, de Vere White R, Pan CX. PMID: 21272294.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    37. Mast cell tumors in a llama (Lama glama). J Vet Diagn Invest. 2010 Sep; 22(5):808-11. Lin TY, Hamberg A, Pentecost R, Wellman M, Stromberg P. PMID: 20807950.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    38. What is your diagnosis? Fine-needle aspirate of an aggressive bone lesion in a dog. Chondrosarcoma. Vet Clin Pathol. 2010 Sep; 39(3):397-8. Lin TY, Hosoya K, Drost WT, Premanandan C, Wellman M. PMID: 20561319.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    39. AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit. Blood. 2010 May 27; 115(21):4217-25. Lin TY, Fenger J, Murahari S, Bear MD, Kulp SK, Wang D, Chen CS, Kisseberth WC, London CA. PMID: 20233974.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    40. Characterization and modulation of canine mast cell derived eicosanoids. Vet Immunol Immunopathol. 2010 May 15; 135(1-2):118-127. Lin TY, London CA. PMID: 20036014.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    41. Generation and characterization of novel canine malignant mast cell line CL1. Vet Immunol Immunopathol. 2009 Jan 15; 127(1-2):114-24. Lin TY, Thomas R, Tsai PC, Breen M, London CA. PMID: 19054577.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    42. The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors. Exp Hematol. 2008 Oct; 36(10):1266-77. Lin TY, Bear M, Du Z, Foley KP, Ying W, Barsoum J, London C. PMID: 18657349.
      View in: PubMed   Mentions: 33     Fields:    Translation:AnimalsCells
    43. A functional comparison of canine and murine bone marrow derived cultured mast cells. Vet Immunol Immunopathol. 2006 Dec 15; 114(3-4):320-34. Lin TY, London CA. PMID: 17027994.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    44. Generation and characterization of bone marrow-derived cultured canine mast cells. Vet Immunol Immunopathol. 2006 Sep 15; 113(1-2):37-52. Lin TY, Rush LJ, London CA. PMID: 16780961.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    Tzu-Yin's Networks
    Concepts (248)
    Derived automatically from this person's publications.
    _
    Co-Authors (19)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _